Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

216
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
216
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

311
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
311
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

142
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
142
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

181
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
181
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

264
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
264
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

252
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
252

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness of Ultrasound-guided versus Landmark-based Glucocorticoid Injection in the Treatment of First Carpometacarpal Joint Osteoarthritis.

POCUS journalยท2023
See all related articles

Related Experiment Video

Updated: Jan 3, 2026

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
12:24

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Published on: June 20, 2014

10.3K

Myocarditis as a lupus challenge: two case reports.

Shamma Ahmad Al-Nokhatha1, Hiba Ibrahim Khogali2, Maryam Abdulla Al Shehhi2

  • 1Department of Rheumatology, Internal Medicine, Tawam Hospital, Al Ain, United Arab Emirates. snokhatha@seha.ae.

Journal of Medical Case Reports
|November 21, 2019
PubMed
Summary

Systemic lupus erythematosus can present as myocarditis, a serious heart condition. Early diagnosis and treatment with steroids and immunosuppressants are crucial for managing lupus myocarditis and preventing severe outcomes.

Keywords:
Heart failureMixed connective tissue diseaseMycophenolate mofetilMyocarditisSystemic lupus erythematosus

Related Experiment Videos

Last Updated: Jan 3, 2026

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
12:24

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Published on: June 20, 2014

10.3K

Area of Science:

  • Cardiology
  • Rheumatology
  • Immunology

Background:

  • Myocarditis is a rare but serious cardiac manifestation of systemic lupus erythematosus (SLE).
  • Clinical presentation of lupus myocarditis varies from subclinical to life-threatening.
  • This study reports two cases of myocarditis as the initial presentation of SLE.

Observation:

  • Two Emirati patients diagnosed with mixed connective tissue disease (SLE predominant) and SLE presented with myocarditis.
  • Extensive workup excluded other causes of myocarditis.
  • Patients received pulsed steroids, oral steroids, hydroxychloroquine, and mycophenolate mofetil as needed.

Findings:

  • Both patients showed dramatic symptom improvement within weeks of treatment.
  • Mycophenolate mofetil was utilized for induction of remission, a role beyond its typical maintenance therapy in lupus myocarditis.
  • Treatment included corticosteroids, immunosuppressive agents, and supportive heart failure medications.

Implications:

  • Early recognition and prompt treatment of lupus myocarditis are essential to prevent fatal outcomes.
  • This case highlights the importance of considering myocarditis in SLE patients, even with atypical presentations.
  • Aggressive immunosuppressive therapy, including mycophenolate mofetil, can be effective in managing lupus myocarditis.